Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Geoffrey Maina, Layane Fernandes de Sousa, Solomon Mcharo & Sarah Kiburi. (2021) Risk perceptions and recovery threats for clients with a history of methadone maintenance therapy dropout. Journal of Substance Use 26:6, pages 594-598.
Read now
Read now
Ashly E Jordan, David C Perlman, Daniel J Smith & Holly Hagan. (2018) Application of an adapted PRECIS-2 instrument to assess efficacy- and effectiveness-study designs in a systematic review of intervention studies of the hepatitis C virus-care continuum among people who use drugs. Comparative Effectiveness Research 8, pages 3-17.
Read now
Read now
Jacqueline A Richmond, Suzanne Sheppard-Law, Susan Mason & Sherryne L Warner. (2016) The Australasian Hepatology Association consensus guidelines for the provision of adherence support to patients with hepatitis C on direct acting antivirals. Patient Preference and Adherence 10, pages 2479-2489.
Read now
Read now
R Douglas Bruce, David E Moody, Frederick L Altice, Marc N Gourevitch & Gerald H Friedland. (2013) A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Review of Clinical Pharmacology 6:3, pages 249-269.
Read now
Read now
Articles from other publishers (37)
Michael P. Barry, Elizabeth J. Austin, Elenore P. Bhatraju, Sara N. Glick, Joanne D. Stekler, Elyse L. Tung, Ryan N. Hansen, Emily C. Williams, Alexander J. Gojic, Eleanor I. Pickering & Judith I. Tsui. (2022) Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA. Harm Reduction Journal 19:1.
Crossref
Crossref
Marwa M. Ahmed, Hagar O. Shaarawy, Ismail Anwar & Mai D. Sarhan. (2021) Barriers to Completing Therapy for Hepatitis C with Direct-Acting Antivirals: A Real-Life Experience from a Single Treatment Center in Egypt. Journal of Primary Care & Community Health 12, pages 215013272110080.
Crossref
Crossref
Geert Robaeys & Rob Bielen. 2021. Hepatitis C: Care and Treatment. Hepatitis C: Care and Treatment
191
211
.
Gordana Avramovic, Cristiana Oprea, Julian Surey, Alistair Story, Juan Macías, Walter Cullen, Maria Iglesias, Tina Mc Hugh, Des Crowley, Anna Marie Naughton, Aidan Horan, Irina Ianache, Stefan Lazar, Ionut Popa, Dee Menezes & John S Lambert. (2020) HepCare Europe—A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA. International Journal of Infectious Diseases 91, pages 246-251.
Crossref
Crossref
Anna Y Palmer, Amanda J Wade, Bridget Draper, Jessica Howell, Joseph S Doyle, Dennis Petrie, Alexander J Thompson, David P Wilson, Margaret E Hellard & Nick Scott. (2020) A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment. International Journal of Drug Policy 76, pages 102633.
Crossref
Crossref
Davoud Pourmarzi, Lisa Hall, Andrew Smirnov, Julie Hepworth, Tony Rahman & Gerard FitzGerald. (2020) Framework for community-based models for treating hepatitis C virus. Australian Health Review 44:3, pages 459.
Crossref
Crossref
Ellen Childs, Sabrina A. Assoumou, Katie B. Biello, Dea L. Biancarelli, Mari-Lynn Drainoni, Alberto Edeza, Peter Salhaney, Matthew J. Mimiaga & Angela R. Bazzi. (2019) Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduction Journal 16:1.
Crossref
Crossref
Jørn Henrik Vold, Christer Aas, Rafael Alexander Leiva, Peter Vickerman, Fatemeh Chalabianloo, Else-Marie Løberg, Kjell Arne Johansson & Lars Thore Fadnes. (2019) Integrated care of severe infectious diseases to people with substance use disorders; a systematic review. BMC Infectious Diseases 19:1.
Crossref
Crossref
Alain H. Litwin, John Jost, Katherine Wagner, Moonseong Heo, Alison Karasz, Judith Feinberg, Arthur Y. Kim, Paula J. Lum, Shruti H. Mehta, Lynn E. Taylor, Judith I. Tsui, Irene Pericot-Valverde & Kimberly Page. (2019) Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study. Contemporary Clinical Trials 87, pages 105859.
Crossref
Crossref
Suzanne Barror, Gordana Avramovic, Cristiana Oprea, Julian Surey, Alistair Story, Juan Macías, Walter Cullen, Des Crowley, Aidan Horan, Anna Marie Naughton, Maria Iglesias, Irina Ianache, Stefan Lazar, Ionut Popa, Tina McHugh, Dee Menezes, Willard Tinago & John S Lambert. (2019) HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study. Journal of Antimicrobial Chemotherapy 74:Supplement_5, pages v39-v46.
Crossref
Crossref
M. Eugenia Socías, Mohammad Karamouzian, Stephanie Parent, José Barletta, Kathleen Bird & Lianping Ti. (2019) Integrated models of care for people who inject drugs and live with hepatitis C virus: A systematic review. International Journal of Drug Policy 72, pages 146-159.
Crossref
Crossref
Stefanie N. Rezansoff, Akm Moniruzzaman & Julian M. Somers. (2019) Temporal associations between medication adherence for patients with schizophrenia and opioid dependence: A 17-year Canadian Cohort Study. Schizophrenia Research 210, pages 157-163.
Crossref
Crossref
Davoud Pourmarzi, Lisa Hall, Julie Hepworth, Andrew Smirnov, Tony Rahman & Gerrard FitzGerald. (2019) Clinical effectiveness, cost effectiveness and acceptability of community-based treatment of hepatitis C virus infection: A mixed method systematic review. Journal of Viral Hepatitis 26:4, pages 432-453.
Crossref
Crossref
Judith I. Tsui, Claire M. Miller, John D. Scott, Maria A. Corcorran, Julia C. Dombrowski & Sara N. Glick. (2019) Hepatitis C continuum of care and utilization of healthcare and harm reduction services among persons who inject drugs in Seattle. Drug and Alcohol Dependence 195, pages 114-120.
Crossref
Crossref
Jean-Michel Delile, Victor de Ledinghen, Marie Jauffret-Roustide, Perrine Roux, Brigitte Reiller, Juliette Foucher & Daniel Dhumeaux. (2018) Hepatitis C virus prevention and care for drug injectors: the French approach. Hepatology, Medicine and Policy 3:1.
Crossref
Crossref
A. J. Wade, J. S. Doyle, E. Gane, C. Stedman, B. Draper, D. Iser, S. K. Roberts, W. Kemp, D. Petrie, N. Scott, P. Higgs, P. A. Agius, J. Roney, L. Stothers, A. J. Thompson & M. E. Hellard. (2018) Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial. Trials 19:1.
Crossref
Crossref
A. J. Wade, A. McCormack, C. Roder, K. McDonald, M. Davies, N. Scott, M. Wardrop, E. Athan & M. E. Hellard. (2018) Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C. Journal of Viral Hepatitis 25:9, pages 1089-1098.
Crossref
Crossref
Brianna L. Norton, Matthew J. Akiyama, Philippe J. Zamor & Alain H. Litwin. (2018) Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy. Infectious Disease Clinics of North America 32:2, pages 347-370.
Crossref
Crossref
Joseph K. Lim. (2018) Expanding Capacity to Treat Hepatitis C: Overcoming Barriers and New Innovations. Current Hepatology Reports 17:2, pages 83-87.
Crossref
Crossref
Cara L. McDermott, Catherine M. Lockhart & Beth Devine. (2018) Outpatient directly observed therapy for hepatitis C among people who use drugs: a systematic review and meta-analysis. Journal of Virus Eradication 4:2, pages 118-122.
Crossref
Crossref
Roman Shrestha, Pramila Karki, Frederick L. Altice, Oleksandr Dubov, Liana Fraenkel, Tania Huedo-Medina & Michael Copenhaver. (2017) Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users. AIDS and Behavior 22:4, pages 1228-1238.
Crossref
Crossref
S. S. Solomon, M. S. Sulkowski, P. Amrose, A. K. Srikrishnan, A. M. McFall, B. Ramasamy, M. S. Kumar, S. Anand, D. L. Thomas & S. H. Mehta. (2018) Directly observed therapy of sofosbuvir/ribavirin +/− peginterferon with minimal monitoring for the treatment of chronic hepatitis C in people with a history of drug use in Chennai, India (C-DOT). Journal of Viral Hepatitis 25:1, pages 37-46.
Crossref
Crossref
Sheila Williams. (2018) Impact of Nursing Interventions on Medication Adherence During Hepatitis C Treatment. Gastroenterology Nursing 41:5, pages 436-445.
Crossref
Crossref
R Douglas Bruce, Jessica Merlin, Paula J Lum, Ebtesam Ahmed, Carla Alexander, Amanda H Corbett, Kathleen Foley, Kate Leonard, Glenn Jordan Treisman & Peter Selwyn. (2017) 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV. Clinical Infectious Diseases 65:10, pages e1-e37.
Crossref
Crossref
Amanda J. Wade, Vanessa Veronese, Margaret E. Hellard & Joseph S. Doyle. (2016) A systematic review of community based hepatitis C treatment. BMC Infectious Diseases 16:1.
Crossref
Crossref
Kali Zhou, Thomas Fitzpatrick, Nick Walsh, Ji Young Kim, Roger Chou, Mellanye Lackey, Julia Scott, Ying-Ru Lo & Joseph D Tucker. (2016) Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses. The Lancet Infectious Diseases 16:12, pages 1409-1422.
Crossref
Crossref
Nancy Reau, Michael W. Fried, David R. Nelson, Robert S. BrownJrJr, Gregory T. Everson, Stuart C. Gordon, Ira M. Jacobson, Joseph K. Lim, Paul J. Pockros, K. Rajender Reddy & Kenneth E. Sherman. (2015) HCV Council – critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape. Liver International 36:4, pages 488-502.
Crossref
Crossref
Amanda J. Wade, Diana M. Macdonald, Joseph S. Doyle, Adam Gordon, Stuart K. Roberts, Alexander J. Thompson & Margaret E. Hellard. (2015) The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service. PLOS ONE 10:11, pages e0142770.
Crossref
Crossref
Jaimie P. Meyer, Yavar Moghimi, Ruthanne Marcus, Joseph K. Lim, Alain H. Litwin & Frederick L. Altice. (2015) Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. International Journal of Drug Policy 26:10, pages 922-935.
Crossref
Crossref
Mollie E. Miller & Stacey C. Sigmon. (2015) Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions: Table 1.. Nicotine & Tobacco Research 17:8, pages 955-959.
Crossref
Crossref
Jamie P. Morano, Alexei Zelenev, Andrea Lombard, Ruthanne Marcus, Britton A. Gibson & Frederick L. Altice. (2014) Strategies for Hepatitis C Testing and Linkage to Care for Vulnerable Populations: Point-of-Care and Standard HCV Testing in a Mobile Medical Clinic. Journal of Community Health 39:5, pages 922-934.
Crossref
Crossref
Haider Abdulrazzaq Abed Al-Darraji, Kee Cheong Wong, David Gan Eng Yeow, Jeannia Jiani Fu, Kelsey Loeliger, Christopher Paiji, Adeeba Kamarulzaman & Frederick L. Altice. (2014) Tuberculosis screening in a novel substance abuse treatment center in Malaysia: Implications for a comprehensive approach for integrated care. Journal of Substance Abuse Treatment 46:2, pages 144-149.
Crossref
Crossref
Thomas F. Kresina, Robert Lubran, H. Westley Clark & Elinore F. McCance-Katz. (2014) Advancing Service Integration in Opioid Treatment Progams for the Care and Treatment of Hepatitis C Infection. International Journal of Clinical Medicine 05:03, pages 118-125.
Crossref
Crossref
R. Douglas Bruce, Barrot Lambdin, Olivia Chang, Frank Masao, Jessie Mbwambo, Ibrahim Mteza, Cassian Nyandindi, Sophia Zamudio-Haas, Deus Buma, Megan S. Dunbar & Gad Kilonzo. (2014) Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. International Journal of Drug Policy 25:1, pages 22-25.
Crossref
Crossref
Bernd Schulte, Christiane Sybille Schmidt, Olaf Kuhnigk, Ingo Schäfer, Benedikt Fischer, Heiner Wedemeyer & Jens Reimer. (2013) Structural barriers in the context of opiate substitution treatment in Germany - a survey among physicians in primary care. Substance Abuse Treatment, Prevention, and Policy 8:1.
Crossref
Crossref
Jamie P. Morano, Mary R. Walton, Alexei Zelenev, R. Douglas Bruce & Frederick L. Altice. (2013) Latent Tuberculosis Infection: Screening and Treatment in an Urban Setting. Journal of Community Health 38:5, pages 941-950.
Crossref
Crossref
R. Douglas Bruce. (2013) Is It Time for Treatment as Prevention Among People Who Inject Drugs?. JAIDS Journal of Acquired Immune Deficiency Syndromes 63:5, pages 545-547.
Crossref
Crossref